These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29682513)

  • 1. Lung cancer stem cells-origin, characteristics and therapy.
    Prabavathy D; Swarnalatha Y; Ramadoss N
    Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer.
    Lee HY; Hong IS
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
    Yin H; Deng J
    Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
    Januchowski R; Wojtowicz K; Zabel M
    Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer stem cells and implications for future therapeutics.
    Wang J; Li ZH; White J; Zhang LB
    Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting.
    Lu B; Huang X; Mo J; Zhao W
    Front Pharmacol; 2016; 7():84. PubMed ID: 27148051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal cancer stem cells and implications for future therapeutics.
    Qian X; Tan C; Wang F; Yang B; Ge Y; Guan Z; Cai J
    Onco Targets Ther; 2016; 9():2247-54. PubMed ID: 27143920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study.
    Masciale V; Grisendi G; Banchelli F; D'Amico R; Maiorana A; Sighinolfi P; Stefani A; Morandi U; Dominici M; Aramini B
    Front Oncol; 2019; 9():1394. PubMed ID: 31921651
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer stem cells in solid tumors by vitamin D.
    So JY; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA).
    Jasim SA; Salahdin OD; Malathi H; Sharma N; Rab SO; Aminov Z; Pramanik A; Mohammed IH; Jawad MA; Gabel BC
    Cell Biochem Biophys; 2024 Dec; 82(4):3031-3051. PubMed ID: 39060914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-detection of ALDH1A1, ABCG2, ALCAM and CD133 in three A549 subpopulations at the single cell level by one-step digital RT-PCR.
    Xu Y; Hu J; Zhu Q; Song Q; Mu Y
    Integr Biol (Camb); 2018 Jun; 10(6):364-369. PubMed ID: 29808880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.